About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,862 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,862 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 561-580 of 28,862 trials

CompletedSpironolactone for Reducing Proteinuria in Diabetic NephropathyIntroduction: Aldosterone seems to have deleterious effects on the kidneys.NCT00498537·Dayton, Ohio CompletedML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD.NCT05081245·Dothan, Alabama and 28 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

CompletedIntervenous (IV) Zoledronic Acid After Forteo in Postmenopausal WomenThe purpose of this study is to evaluate the adequacy of zoledronic acid in maintaining bone mass after two years of treatment with Forteo, in postmenopausal women.NCT00361595·Cleveland, Ohio

TerminatedPanobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by SurgeryRATIONALE: Panobinostat and sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00873002·Cleveland, Ohio

CompletedPostoperative Environment on Pain Following Pelvic Reconstructive SurgeryThis study is to determine if patients following prolapse repair including vaginal vault suspension have decreased pain measured via a visual analog scale (VAS) on postoperative…NCT03379753·Cincinnati, Ohio

CompletedEffect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACSA placebo-controlled, randomized, double-blind, parallel group, phase III multicenter study in subjects recently hospitalized for ACS and with the appropriate genetic profile.NCT02525939·Alexander City, Alabama and 556 others

CompletedVolume Optimization Incorporating Negative Pressure Diuresis in Heart Failure (VOID-HF)The Cardiorenal Syndrome during Acute decompensated heart failure (ADHF) with persistent congestion despite high dose IV diuretic therapy is associated with remarkable morbidity…NCT04227977·Gainesville, Florida and 3 others

CompletedVitamin D Replacement Using Oral Thin Film (OTF) Cholecalciferol in Patients Undergoing Hematopoietic Stem Cell TransplantationThe investigators hypothesize that vitamin D levels can be improved in hematopoietic stem cell transplantation (HSCT) recipients not responding or tolerating standard enteral…NCT04818957·Cincinnati, Ohio

CompletedStudy of Nivolumab (BMS-936558) Plus Ipilimumab Compared With Ipilimumab Alone in the Treatment of Previously Untreated, Unresectable, or Metastatic MelanomaThe primary purpose of this study is to compare the objective response rate, as determined by investigators, of Nivolumab combined with Ipilimumab versus Ipilimumab monotherapy in…NCT01927419·San Francisco, California and 20 others

CompletedCrystalloid Liberal or Vasopressors Early Resuscitation in SepsisMulticenter, prospective, phase 3 randomized non-blinded interventional trial of fluid treatment strategies in the first 24 hours for patients with sepsis-induced hypotension.NCT03434028·Tucson, Arizona and 49 others

RecruitingATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersIn parallel with the growth of ATHN's clinical studies, the number of new therapies for all blood disorders is increasing significantly.NCT04398628·Phoenix, Arizona and 75 others

CompletedBipolar II Depression: Lithium, SSRI, or the CombinationThis study will compare the safety and effectiveness of a mood stabilizing medication, an antidepressant medication, and a combination of both medications to treat symptoms of…NCT00276965·Los Angeles, California and 2 others

CompletedZuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)The primary purpose of this study is to evaluate the pharmacokinetics and safety of Zuranolone in adolescents (ages 12 to 17 years) with MDD.NCT05655507·Atlanta, Georgia and 3 others

CompletedEfficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative ColitisThe objective of this study is to assess the efficacy and safety of adalimumab for the induction of clinical remission in subjects with moderately to severely active ulcerative…NCT00385736·Birmingham, Alabama and 79 others

CompletedSym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor MalignanciesThe study will evaluate the preliminary efficacy of 3 combinations (Sym021+Sym022, Sym021+Sym023 and Sym021+Sym023+irinotecan) in patients with biliary tract carcinomas (BTC) and…NCT04641871·Aurora, Colorado and 16 others

WithdrawnRapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) TestA multi-centered, prospective study, involving pregnant women presenting to the labor and delivery unit of collaborating clinical study sites with preterm labor and intact…NCT03497234·Long Beach, California and 4 others

CompletedEfficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With SchizophreniaNegative symptoms and cognitive dysfunction in schizophrenia (CDS) are core features of schizophrenia.NCT01488929·Garden Grove, California and 63 others

TerminatedUse of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing HemodialysisThis study is designed to confirm the safety of the proposed dose and schedule of ABI-007 for hemodialysis patients with vascular access device failure, and to obtain preliminary…NCT00249002·Peoria, Illinois and 3 others

CompletedYIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)The aim of this study is to compare the efficacy and safety of YIV-906 plus standard-of-care sorafenib versus those of sorafenib alone as a first-line systemic treatment for…NCT04000737·Flushing, New York and 23 others

CompletedGenetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer SurvivorsThis clinical trial studies cancer survivors to identify those who are at increased risk of developing late-occurring complications after undergoing treatment for childhood cancer.NCT00082745·Birmingham, Alabama and 155 others

PreviousPage 29 of 1444Next

Heart Diseasein Ohio